Mojtaba Lotfaliany; Mohamad Ali Mansournia; Fereidoun Azizi; Farzad Hadaegh; Neda Zafari; Arash Ghanbarian; Parvin Mirmiran; Brian Oldenburg; Davood Khalili

Different Metabolic Phenotypes of Obesity and 2 Decades Risk of Cardio–Renal–Metabolic Multimorbidity: Tehran Lipid and Glucose Study

Journal of the American Heart Association 14(18) (2025)

Danial Molavizadeh; Soroush Masrouri; Farzad Esmaeili; Fereidoun Azizi; Farzad Hadaegh

Nonparametric estimation of bivariate cumulative distribution function

Arabian Journal of Mathematics 13(3) (2024)

Behzad Mansouri; Azam Rastin; Habib Allah Mombeni

Changes in Fasting plasma glucose status and risk of mortality events in individuals without diabetes over two decades of Follow-up: a pooled cohort analysis

Cardiovascular Diabetology 21(1) (2022)

Karim Kohansal; Soroush Masrouri; Davood Khalili; Azra Ramezankhani; Fereidoun Azizi; Michael J Blaha; Farzad Hadaegh

The impact of long-term exposure to PM10, SO2, O3, NO2, and CO on incident dysglycemia: a population-based cohort study

Environmental Science and Pollution Research 30(2) (2023)

Seyed Saeed Tamehri Zadeh; Alireza Khajavi; Azra Ramezankhani; Fereidoun Azizi; Farzad Hadaegh

Sex differences in risk factors for coronary heart disease events: a prospective cohort study in Iran

Scientific Reports 13(1) (2023)

Azra Ramezankhani; Fereidoun Azizi; Farzad Hadaegh

The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study

Annals of Medicine 54(1) (2022)

Rahele Rasooli; Azra Ramezankhani; Davood Khalili; Maryam Tohidi; Mitra Hasheminia; Fereidoun Azizi; Farzad Hadaegh

Association of body mass index with life expectancy with and without cardiovascular disease

International Journal of Obesity 44(1) (2020)

Nazanin Fekri; Pegah Khaloo; Azra Ramezankhani; Mohammad Ali Mansournia; Fereidoun Azizi; Farzad Hadaegh

Kidney function decline is associated with mortality events: over a decade of follow-up from Tehran Lipid and Glucose Study

Journal of Nephrology 37(1) (2023)

Soroush Masrouri; Seyed Saeed Tamehri Zadeh; Mehdi Pishgahi; Fereidoun Azizi; Michael D. Shapiro; Farzad Hadaegh

Evaluation of the effectiveness of the Iran-package of essential non-communicable disease (IraPEN) program in reducing cardiovascular disease risk in pilot areas

BMC Public Health 25(1) (2025)

Somayeh Derakhshan; Davood Khalili; Alireza Mahdavi; Seyed-Saeed Hashemi-Nazari; Amir Kavousi; Fatemeh Hadavandsiri; Afshin Ostovar; Koorosh Etemad

Factors associated with smoking intensity among adult smokers: findings from the longitudinal cohort of the Tehran lipid and glucose study

BMC Public Health 23(1) (2023)

Marjan Abbasi-Dokht-Rafsanjani; Samaneh Hosseinzadeh; Enayatollah Bakhshi; Fereidoun Azizi; Davood Khalili

Contributions and Implications of the Tehran Lipid and Glucose Study

International Journal of Endocrinology and Metabolism 16(4 (Suppl)) (2018)

Fereidoun Azizi; Miralireza Takyar; Azita Zadeh-Vakili

Mean versus variability of lipid measurements over 6 years and incident cardiovascular events: More than a decade follow-up

Frontiers in Cardiovascular Medicine 9 (2022)

Soroush Masrouri; Leila Cheraghi; Niloofar Deravi; Neda Cheraghloo; Maryam Tohidi; Fereidoun Azizi; Farzad Hadaegh

The impact of general and central obesity for all-cause hospitalization among Iranian adults: a 20 year follow-up-results from the TLGS cohort

BMC Public Health 23(1) (2023)

Azra Ramezankhani; Fereidoun Azizi; Mitra Hasheminia; Farzad Hadaegh

Association between estimated glomerular filtration rate slope and cardiovascular disease among individuals with and without diabetes: a prospective cohort study

Cardiovascular Diabetology 22(1) (2023)

Azra Ramezankhani; Fereidoun Azizi; Farzad Hadaegh

Anthropometric indices and the risk of incident sudden cardiac death among adults with and without diabetes: over 15 years of follow-up in The Tehran Lipid and Glucose Study

Diabetology & Metabolic Syndrome 13(1) (2021)

Seyyed Saeed Moazzeni; Seyed Saeed Tamehri Zadeh; Samaneh Asgari; Fereidoun Azizi; Farzad Hadaegh

External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population

Journal of Translational Medicine 18(1) (2020)

Samaneh Asgari; Fatemeh Moosaie; Davood Khalili; Fereidoun Azizi; Farzad Hadaegh

Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study

Frontiers in Cardiovascular Medicine 9 (2022)

Samaneh Asgari; Soroush Masrouri; Davood Khalili; Fereidoun Azizi; Farzad Hadaegh

The clinical value of metabolic syndrome and its components with respect to sudden cardiac death using different definitions: Two decades of follow-up from the Tehran Lipid and Glucose Study

Cardiovascular Diabetology 21(1) (2022)

Soroush Masrouri; Seyyed Saeed Moazzeni; Neda Cheraghloo; Fereidoun Azizi; Farzad Hadaegh